Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Moshe Arkin

Affiliations

  • Large Shareholder at Keros Therapeutics Inc. (KROS), 2020-04-13
  • Director at Perrigo Co (PRGO), 2011-09-02
  • Large Shareholder, Other at Neurogesx Inc (NGSX), 2011-08-12
  • Other at Orexigen Therapeutics Inc. (OREX), 2010-08-16
  • Large Shareholder, Director at Ophthalmic Imaging Systems (OISI), 2010-06-10
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NGSX $5.50 30,000 Large Shareholder, Other 2,648,107 2010-09-09 Filing
NGSX $7.18 7,200 Large Shareholder, Other 2,495,304 2010-01-22 Filing
NGSX $7.09 8,768 Large Shareholder, Other 2,488,104 2010-01-21 Filing
NGSX $7.10 1,300 Large Shareholder, Other 2,479,336 2010-01-20 Filing
NGSX $7.10 209 Large Shareholder, Other 2,478,036 2010-01-19 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PRGO $96.20 52,591 Director 4,983,267 2011-08-31 Filing
PRGO $95.18 13,715 Director 5,035,828 2011-08-31 Filing
PRGO $94.55 13,549 Director 5,049,573 2011-08-31 Filing
PRGO $96.46 170,145 Director 5,063,122 2011-08-30 Filing
NGSX $2.00 82,109 Large Shareholder, Other 0 2011-08-10 Filing